Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial
United States, Cambridge: Elsevier (2022)
Despite encouraging preclinical and limited clinical findings, substantial gaps remain regarding its bioavailability, pharmacodynamics, and efficacy in well-controlled human trials
Our health education programs and unique, whole-person approach are critical to achieving it
Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome
"It's actively happening, but I would call it just the start and the potential is huge," said Jim Owen, senior analyst for packaging and logistics at RaboResearch, referencing the drugs' proliferation and influence